| 4.07 -0.06 (-1.45%) | 10-04 10:34 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.89 | 1-year : | 5.71 |
| Resists | First : | 4.19 | Second : | 4.89 |
| Pivot price | 3.69  |
|||
| Supports | First : | 3.52 |
Second : | 3.11 |
| MAs | MA(5) : | 3.88 |
MA(20) : | 3.62 |
| MA(100) : | 3.79  |
MA(250) : | 5.33 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 88.8 |
D(3) : | 88.2 |
| RSI | RSI(14): 66.9 |
|||
| 52-week | High : | 10.6 | Low : | 2.9 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ PETS ] has closed below upper band by 6.4%. Bollinger Bands are 1.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.2 - 4.21 | 4.21 - 4.23 |
| Low: | 3.79 - 3.81 | 3.81 - 3.83 |
| Close: | 4.1 - 4.13 | 4.13 - 4.16 |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Fri, 04 Oct 2024
Cubist Systematic Strategies LLC Acquires New Holdings in PetMed Express, Inc. (NASDAQ:PETS) - MarketBeat
Fri, 27 Sep 2024
PetMed Express adopts new inducement incentive plan - Investing.com
Mon, 23 Sep 2024
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Fri, 20 Sep 2024
PetMed Express, Inc. (NASDAQ:PETS) Shares Acquired by Federated Hermes Inc. - MarketBeat
Wed, 18 Sep 2024
Insider Stock Buyers At PetMed Express Recouped Some Losses This Week - Simply Wall St
Thu, 12 Sep 2024
PetMed Express, Inc. Announces Appointment of Robyn D’Elia as Chief Financial Officer - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 0 (M) |
| Shares Float | 21 (M) |
| Held by Insiders | 1.892e+007 (%) |
| Held by Institutions | 4.2 (%) |
| Shares Short | 1,790 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 5.37e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 275 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 8.4 % |
| Return on Equity (ttm) | 0.1 % |
| Qtrly Rev. Growth | 2.7077e+008 % |
| Gross Profit (p.s.) | -18.86 |
| Sales Per Share | -3.72 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -0.2 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | 0 |
| PEG Ratio | -2 |
| Price to Book value | 0 |
| Price to Sales | -1.08 |
| Price to Cash Flow | 0.61 |
| Dividend | 0 |
| Forward Dividend | 2.11e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|